Molecular Epidemiology and Drug Resistance of Acinetobacter baumannii Isolated from Hospitals in Southern Poland: ICU as a Risk Factor for XDR Strains

Microbial Drug Resistance

Volumn 22, Issue 4, 2016, Pages 328-335

  Chmielarczyk, Agnieszka ^a   Pilarczyk Zurek, Magdalena ^a   Kamińska, Wanda ^b   Pobiega, Monika ^a   Romaniszyn, Dorota ^a   Ziółkowski, Grzegorz ^c   Wójkowska Mach, Jadwiga ^a   Bulanda, Małgorzata ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^c Higher School of Medicine in Sosnowiec   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULTAMICILLIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ACINETOBACTER INFECTION; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CLONE; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MENINGOENCEPHALITIS; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PNEUMONIA; POLAND; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BACTEREMIA; CELL CLONE; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HORIZONTAL GENE TRANSFER; HOSPITAL; INCIDENCE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE; PHYLOGENY; PLASMID; PNEUMONIA, BACTERIAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CLONE CELLS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENE EXPRESSION; GENE TRANSFER, HORIZONTAL; HOSPITALS; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; PLASMIDS; PNEUMONIA, BACTERIAL; POLAND; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84973661528     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2015.0224     Document Type: Article

References (41)

1. AB bioMerieux. 2009. Summary of Etest Performance, Interpretative Criteria and Quality Control Ranges -table AB bioMerieux Document, 05; Solna.
2. Aly, M., H.T. Tayeb, S.M. Al Johani, E.J. Alyamani, F. Aldughaishem, I. Alabdulkarim, and H.H. Balkhy. 2014. Genetic diversity of OXA-51-like genes among multidrugresistant Acinetobacter baumannii in Riyadh, Saudi Arabia. Eur. J. Clin. Microbiol. Infect. Dis. 33:1223-1228.
3. Carvalho, K.R., A.P. Carvalho-Assef, G. Peirano, L.C. Santos, M.J. Pereira, and M.D. Asensi. 2009. Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil. Int. J. Antimicrob. Agents 34: 25-28.
4. Chmielarczyk, A., P.G. Higgins, J. Wojkowska-Mach, E. Synowiec, E. Zander, D. Romaniszyn, T. Gosiewski, H. Seifert, P. Heczko, and M. Bulanda. 2012. Control of an outbreak of Acinetobacter baumannii infections using vaporized hydrogen peroxide. J. Hosp. Infect. 81:239-245.
5. Cieslinski, J.M., L. Arend, F.F. Tuon, E.P. Silva, R.G. Ekermann, L.M. Dalla-Costa, P.G. Higgins, H. Seifert, and M. Pilonetto. 2013. Molecular epidemiology characterization of OXA-23 carbapenemase-producing Acinetobacter baumannii isolated from 8 Brazilian hospitals using repetitive sequence-based PCR. Diagn. Microbiol. Infect. Dis. 77:337-340.
6. Clinical and Laboratory Standards Institute. 2011. Performance Standards for Antimicrobial Susceptibility Testing. Twenty-First Informational Supplement. Document M100-S21. CLSI, Wayne, PA.
7. Diancourt, L., V. Passet, A. Nemec, L. Dijkshoorn, and S. Brisse. 2010. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5:e10034.
8. Dijkshoorn, L., A. Nemec, and H. Seifert. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5:939-951.
9. Ellington, M.J., J. Kistler, D.M. Livermore, and N. Woodford. 2007. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J. Antimicrob. Chemother. 59:321-322.
10. European Antimicrobial Resistance Surveillance Network (EARS-Net). Available at http://ecdc.europa.eu/en/ activities/surveillance/EARS-Net/Pages/index.aspx#sthash. qo59cgN4.dpuf (Online, accessed June 30, 2015.)
11. Falagas, M.E., P. Kopterides, and I.I. Siempos. 2006. Attributable mortality of Acinetobacter baumannii infection among critically ill patients. Clin. Infect. Dis. 43:389; author reply 389-390.
12. Garnacho-Montero, J., and R. Amaya-Villar. 2010. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr. Opin. Infect. Dis. 23:332-339.
13. Healy, M., J. Huong, T. Bittner, M. Lising, S. Frye, S. Raza, R. Schrock, J. Manry, A. Renwick, R. Nieto, C. Woods, J. Versalovic, and J.R. Lupski. 2005. Microbial DNA typing by automated repetitive-sequence-based PCR. J. Clin. Microbiol. 43:199-207.
14. Higgins, P.G., C. Dammhayn, M. Hackel, and H. Seifert. 2010. Global spread of carbapenem-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 65:233-238.
15. Higgins, P.G., K. Janssen, M.M. Fresen, H. Wisplinghoff, and H. Seifert. 2012. Molecular epidemiology of Acinetobacter baumannii bloodstream isolates obtained in the United States from 1995 to 2004 using rep-PCR and multilocus sequence typing. J. Clin. Microbiol. 50:3493-3500.
16. Higgins, P.G., F.J. Pérez-Llarena, E. Zander, A. Fernández, G. Bou, and H. Seifert. 2013. OXA-235, a novel class D b-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 57:2121-2126.
17. Hoban, D.J., R.R. Reinert, S.K. Bouchillon, and M.J. Dowzicky. 2015. Global in vitro activity of tigecycline and comparator agents: tigecycline evaluation and surveillance trial 2004-2013. Ann. Clin. Microbiol. Antimicrob. 14:27.
18. Hojabri, Z., Z. Hojabri, O. Pajand, C. Bonura, A. Aleo, A. Giammanco, and C. Mammina. 2014. Molecular epidemiology of Acinetobacter baumannii in Iran: endemic and epidemic spread of multiresistant isolates. J. Antimicrob. Chemother. 69:2383-2387.
19. Huang, X.Z., D.M. Cash, M.A. Chahine, M.P. Nikolich, and D.W. Craft. 2012. Development and validation of a multiplex TaqMan real-time PCR for rapid detection of genes encoding four types of class D carbapenemase in Acinetobacter baumannii. J. Med. Microbiol. 61(Pt 11): 1532-1537.
20. Kwon, K.T., W.S. Oh, J.H. Song, H.H. Chang, S.I. Jung, S.W. Kim, S.Y. Ryu, S.T. Heo, D.S. Jung, J.Y. Rhee, S.Y. Shin, K.S. Ko, K.R. Peck, and N.Y. Lee. 2007. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J. Antimicrob. Chemother. 59: 525-530.
21. Lee, K., Y.S.Lim, D.Yong, J.H. Yum, andY.Chong. 2003. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-betalactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 41:4623-4629.
22. López-Rojas, R., M.J. McConnell, M.E. Jiménez-Mejías, J. Domínguez-Herrera, F. Fernández-Cuenca, and J. Pachón. 2013. Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness. Antimicrob. Agents Chemother. 57:4587-4589.
23. Magiorakos, A.P., A. Srinivasan, R.B. Carey, Y. Carmeli, M.A. Falagas, C.G. Giske, S. Harbarth, J.F. Hindler, G. Kahlmeter, B. Olssen-Liljequist, D.L. Paterson, L.B. Rice, J. Stelling, M.J. Struelens, A. Vatopoulos, J.T.Weber, and D.L. Monnet. 2012. Multidrugresistant, extensively drugresistant and pan-drug-resistance bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbial. Infect. 18:268-281.
24. Maragakis, L.L., and T.M. Perl. 2008. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatmentoptions. Clin. Infect. Dis. 46:1254-1263.
25. Mugnier, P.D., L. Poirel, T. Naas, and P. Nordmann. 2010. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis. 16:35-40.
26. Navon-Venezia, S., A. Leavitt, and Y. Carmeli. 2007. High tigecycline resistance inmultidrug-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 59:772-774.
27. Nowak, P., P. Paluchowska, and A. Budak. 2012. Distribution of blaOXA genes among carbapenem-resistant Acinetobacter baumannii nosocomial strains in Poland. New Microbiol. 35:317-325.
28. O'Hara, J.A., L.A. Ambe, L.G. Casella, B.M. Townsend, M.R. Pelletier, R.K. Ernst, R.M. Shanks, and Y. Doi. 2013. Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains. Antimicrob. Agents Chemother. 57:2103-2108.
29. Pasanen, T., S. Koskela, S. Mero, E. Tarkka, P. Tissari, M. Vaara, and J. Kirveskari. 2014. Rapid molecular characterization of Acinetobacter baumannii clones with rep-PCR and evaluation of carbapenemase genes by new multiplex PCR in Hospital District of Helsinki and Uusimaa. PLoS One 9:e85854.
30. Peleg, A.Y., H. Seifert, and D.L. Paterson. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582.
31. Perez, F, A. Endimiani, A.J. Ray, B.K. Decker, C.J. Wallace, K.M. Hujer, D.J. Ecker, M.D. Adams, P. Toltzis, M.J. Dul, A. Windau, S. Bajaksouzian, M.R. Jacobs, R.A. Salata, and R.A. Bonomo. 2010. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. J. Antimicrob. Chemother. 65:1807-1818.
32. Poirel, L., T. Naas, and P. Nordmann. 2010. Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrob. Agents Chemother. 54:24-38.
33. Poirel, L., and P. Nordmann. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826-836.
34. Qureshi, Z.A., L.E. Hittle, J.A. O'Hara, J.I. Rivera, A. Syed, R.K. Shields, A.W. Pasculle, R.K. Ernst, and Y. Doi. 2015. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance. Clin. Infect. Dis. 60:1295-1303.
35. Solomennyi, A., A. Goncharov, and L. Zueva. 2015. Extensively drug-resistant Acinetobacter baumannii belonging to the international clonal lineage I in a Russian burn intensive care unit. Int. J. Antimicrob. Agents 45:525-528.
36. Towner, K.J., B. Evans, L. Villa, K. Levi, A. Hamouda, S.G. Amyes, and A. Carattoli. 2011. Distribution of intrinsic plasmid replicase genes and their association with carbapenem-hydrolyzing class D beta-lactamase genes in European clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 55:2154-2159.
37. Towner, K.J., K. Levi, and M. Vlassiadi. 2008. ARPAC Steering Group. Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe. Clin. Microbiol. Infect. 14:161-167.
38. Turton, J.F., N. Woodford, J. Glover, S. Yarde, M.E. Kaufmann, and T.L. Pitt. 2006. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44:2974-2976.
39. Urban C, S. Segal-Maurer, and J.J. Rahal. 2003. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin. Infect. Dis. 36:1268-1274.
40. Villalón, P., S. Valdezate, T. Cabezas, M. Ortega, N. Garrido, A. Vindel, M.J. Medina-Pascual, and J.A. Saez-Nieto. 2015. Endemic and epidemic Acinetobacter baumannii clones: a twelve-year study in a tertiary care hospital. BMC Microbiol. 15:47.
41. Woodford, N., J.F. Turton, and D.M. Livermore. 2011. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 35:736-755.